My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Vertex Pharmaceuticals (NQ:VRTX)

457.36 -5.77 (-1.25%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

68 69 Next >

US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? ↗

August 01, 2024

Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...

Via Benzinga

Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever ↗

August 01, 2024

These businesses are looking like increasingly attractive buys.

Via The Motley Fool

14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know ↗

July 31, 2024

Via Benzinga

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock. ↗

July 25, 2024

Is VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) suited for quality investing?

Via Chartmill

Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November ↗

August 01, 2024

After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a...

Via Benzinga

The Top 3 Biotech Stocks to Buy Now Summer 2024 ↗

July 31, 2024

These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects.

Via InvestorPlace

Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain

July 30, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals ↗

July 11, 2024

Via Benzinga

Check Out What Whales Are Doing With VRTX ↗

July 10, 2024

Via Benzinga

DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame? ↗

July 30, 2024

DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.

Via The Motley Fool

The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 ↗

July 29, 2024

The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision.

Via InvestorPlace

2 No-Brainer Growth Stocks to Buy With $1,000 Right Now ↗

July 28, 2024

These companies are paving the way to future growth and market share in their respective industries.

Via The Motley Fool

Is Vertex Pharmaceuticals' Monopoly in Danger? ↗

July 25, 2024

As a shareholder, I am nowhere close to panic mode.

Via The Motley Fool

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗

July 25, 2024

Vertex shares have soared by triple-digit percentages over the past three years.

Via The Motley Fool

7 Biotech Stocks to Keep on Your Clinical Radar ↗

July 23, 2024

Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.

Via InvestorPlace

Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today ↗

July 23, 2024

Via Benzinga

3 Gene Editing Stocks Shaping the Future of Medicine ↗

July 22, 2024

Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions

Via InvestorPlace

2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street ↗

July 21, 2024

Neither of these predictive indicators has ever been wrong when back-tested for more than 150 years!

Via The Motley Fool

3 Monster Stocks in the Making to Buy Right Now ↗

July 20, 2024

They're small now, but these stocks could grow much larger.

Via The Motley Fool

The 3 Best Neuroscience Biotech Stocks to Buy Now ↗

July 19, 2024

Given the high bar to developing good neuroscience drugs, firms that do so will likely succeed. Here are three top biotech stocks to buy now.

Via InvestorPlace

Looking for growth without the hefty price tag? Consider NASDAQ:VRTX. ↗

July 19, 2024

VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) is not too expensive for the growth it is showing.

Via Chartmill

3 Gene Editing Stocks That Could Grow Your Wealth ↗

July 17, 2024

Investors looking for gene editing stocks of cutting edge technology firms should consider these biotech stocks.

Via InvestorPlace

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? ↗

July 16, 2024

CRISPR Therapeutics could start reporting product revenue soon.

Via The Motley Fool

Bull Market and Beyond: 2 Stocks Just Waiting to Soar ↗

July 15, 2024

These innovative drugmakers are hard to ignore.

Via The Motley Fool

Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split ↗

July 15, 2024

Revenue is climbing at these two drug companies -- and the trend should continue.

Via The Motley Fool

Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever ↗

July 14, 2024

These companies have what it takes to stand the test of time in a portfolio.

Via The Motley Fool

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024 ↗

July 09, 2024

Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge.

Via InvestorPlace

Healthcare Stocks Continue To Lag The Market-Can Anything Help ? ↗

July 08, 2024

Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.

Via Talk Markets

3 No-Brainer Stocks to Buy in July ↗

July 08, 2024

Investors shouldn't have to think too hard about these great stocks.

Via The Motley Fool

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.